Search research articles
Contact Us
Filters
Showing results (71-80 of 158) with videos related to
Page
of 16
Sort By:
Mutation Research
|
August 1, 1995
Germ line specific factors in chemical mutagenesis
J W Allen, U H Ehling, M M Moore, et al.
Environmental and Molecular Mutagenesis
|
January 1, 1997
Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans
J C Fuscoe, L K Vira, D D Collard, et al.
Mutation Research
|
October 1, 1987
Mutagenicity of actinomycin D in mammalian cells due to clastogenic effects
D M DeMarini, K H Brock, C L Doerr, et al.
Mutation Research
|
February 1, 1988
Mutagenicity and clastogenicity of proflavin in L5178Y/TK +/- -3.7.2.C cells
D M DeMarini, K H Brock, C L Doerr, et al.
Mutation Research
|
November 1, 1991
Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity
K L Dearfield, A E Auletta, M C Cimino, et al.
Carcinogenesis
|
July 1, 1994
Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers
J C Fuscoe, L J Zimmerman, K Harrington-Brock, et al.
Mutation Research
|
March 1, 1987
Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells
D M DeMarini, K H Brock, C L Doerr, et al.
Mutation Research
|
December 1, 1992
Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes
J C Fuscoe, L J Zimmerman, K Harrington-Brock, et al.
Clinical Orthopaedics and Related Research
|
June 1, 1989
Vascularized autografts for reconstruction of skeletal defects following lower extremity trauma. A review
F R Nusbickel, P C Dell, M P McAndrew, et al.
Mutagenesis
|
September 1, 1989
Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci
M M Moore, K Harrington-Brock, C L Doerr, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 158) with videos related to
Sort By:
Page
of 16
Mutation Research
|
August 1, 1995
Germ line specific factors in chemical mutagenesis
J W Allen, U H Ehling, M M Moore, et al.
Environmental and Molecular Mutagenesis
|
January 1, 1997
Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans
J C Fuscoe, L K Vira, D D Collard, et al.
Mutation Research
|
October 1, 1987
Mutagenicity of actinomycin D in mammalian cells due to clastogenic effects
D M DeMarini, K H Brock, C L Doerr, et al.
Mutation Research
|
February 1, 1988
Mutagenicity and clastogenicity of proflavin in L5178Y/TK +/- -3.7.2.C cells
D M DeMarini, K H Brock, C L Doerr, et al.
Mutation Research
|
November 1, 1991
Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity
K L Dearfield, A E Auletta, M C Cimino, et al.
Carcinogenesis
|
July 1, 1994
Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers
J C Fuscoe, L J Zimmerman, K Harrington-Brock, et al.
Mutation Research
|
March 1, 1987
Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells
D M DeMarini, K H Brock, C L Doerr, et al.
Mutation Research
|
December 1, 1992
Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes
J C Fuscoe, L J Zimmerman, K Harrington-Brock, et al.
Clinical Orthopaedics and Related Research
|
June 1, 1989
Vascularized autografts for reconstruction of skeletal defects following lower extremity trauma. A review
F R Nusbickel, P C Dell, M P McAndrew, et al.
Mutagenesis
|
September 1, 1989
Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci
M M Moore, K Harrington-Brock, C L Doerr, et al.
Page
of 16